First Merchants Corporation has declared a quarterly cash dividend of $46.88 per share on its 7.50% Non-Cumulative Perpetual Preferred Stock Series A, represented by depositary shares (NASDAQ: FRMEP) ...
Rein Therapeutics (RNTX), formerly known as Aileron Therapeutics (ALRN), has changed its name to Rein Therapeutics. The new name, logo, ...
MUNCIE, Ind., Jan. 09, 2025 (GLOBE NEWSWIRE) -- First Merchants Corporation (Nasdaq:FRME) will report fourth quarter 2024 financial results on January 30, 2025. The Corporation will host a fourth ...
Detailed price information for Acm Research Inc (ACMR-Q) from The Globe and Mail including charting and trades.
Cintas Corporation (Nasdaq: CTAS) launched its 12 th annual Cintas Custodian of the Year contest, which honors exceptional ...
With the successful CES 2025 demonstration of LeddarVision Surround (LVS-2 +) software utilizing Texas Instruments (“TI”) TDA4VH-Q1 processor, LeddarTech has now received the second advanced royalty ...
Revenue Outlook to $755 to $770 Million- -Projected 2025 Revenue of $850 to $950 Million- -ACM to Participate at Upcoming Conferences- FREMONT, Calif., Jan. 14, 2025 (GLOBE NEWSWIRE) -- ...
Mynaric (MYNA) received a notification letter dated January 9, 2025 from the Listing Qualifications Department of The Nasdaq Stock Market ...
No Immediate Effect on Nasdaq Listing or Trading of the Company’s Ordinary SharesTEL AVIV, Israel, Jan. 15, 2025 (GLOBE NEWSWIRE) -- SciSparc ...
Mr. Wheatley will lead a group presentation and will additionally be available for one-on-one meetings with registered conference attendees. To request a meeting, please use this link to register for ...
Dr. Halden Shane, CEO of TOMI Environmental Solutions, stated, "We are pleased to have regained compliance with Nasdaq's minimum bid price requirement. Our achievements in 2024 underscore our ...
EQS-News: Mynaric AG / Key word (s): Miscellaneous Mynaric Announces Receipt of Deficiency Letters from Nasdaq 15.01.2025 / 15:00 CET/CEST The issuer is solely responsible for the content of this ...